OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma

PURPOSE: Sunitinib offers improved efficacy for patients with metastatic renal cell carcinoma (mRCC). To provide better disease management in the Middle East, we studied its use in mRCC in real-life practice in this region. MATERIAL AND METHODS: Patients diagnosed with mRCC and started on sunitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosn, Marwan, Eid, Roland, Hamada, Emad, Abdel Azim, Hamdy, Zekri, Jamal, Al-Mansour, Mubarak, Jaloudi, Mohammed, Nasr, Fadi, Errihani, Hassan, Bounedjar, Adda, Mezlini, Amel, Boussen, Hamouda, Kattan, Joseph, El Karak, Fadi, Farhat, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825247/
https://www.ncbi.nlm.nih.gov/pubmed/31657977
http://dx.doi.org/10.1200/JGO.18.00238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825247/
https://www.ncbi.nlm.nih.gov/pubmed/31657977
http://dx.doi.org/10.1200/JGO.18.00238

Ejemplares similares